Larissa is Head of Business Development & Licensing for Gene Therapy. In her current role she leads the Business Development for CDMO, the Customer Relationship for internal and external pipeline programs, Business & IP Strategy and Marketing and Communication for the Gene Therapy activities, linked together under the Gene Therapy Center Austria (GTCA) umbrella. In her seven years with the company she held a number of positions with increasing responsibility in R&D and GMS, most of them connected with the Gene Therapy programs.
Prior to joining Baxter Larissa was more than 10 years in the corporate finance business as senior technical and market risk analyst for small and midcap size deals in the area of chemistry, pharma, and biotech.
Larissa holds a PhD in Biochemistry of the University of Vienna.